https://www.taxtmi.com/news?id=52781 The document outlines a commercial "proof-first" policy requiring supplements to contain only patented, clinically validated ingredients, mandating third-party batch testing and online publication of results to address alleged widespread regulatory non-compliance and safety risks from adulterants and contaminants linked to liver and kidney harm. en-us Mon, 18 Aug 2025 16:46:03 +0530 Mon, 18 Aug 2025 16:46:03 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=52781 The document outlines a commercial "proof-first" policy requiring supplements to contain only patented, clinically validated ingredients, mandating third-party batch testing and online publication of results to address alleged widespread regulatory non-compliance and safety risks from adulterants and contaminants linked to liver and kidney harm. News - Mon, 18 Aug 2025 16:46:03 +0530 https://www.taxtmi.com/news?id=52781